Fry, DW (2003) Mechanism of action of erbB tyrosine kinase inhibitors. Exp Cell Res 284: pp. 131-139Fry DW ( 2003 ) Mechanism of action of erbB tyrosine kinase inhibitors . Exp Cell Res 284 : 131 – 139Fry, D.W.: Mechanism of action of erbB tyrosine kinase inhibitors. Exp. Cell ...
产品名称:酪氨酸激酶抑制剂(Tyrosine kinase inhibitor) 英文名称:Tyrosine kinase inhibitor 产品货号:M02479 产品规格:1mL(10mM)|5mg 本产品为酪氨酸激酶抑制剂。 注:本品仅可用于科研实验,严禁用于临床医疗及其他用途! CAS号:1021950-26-4 纯度:99.78% ...
Tyrosine kinase inhibitor产品规格:1mL(10mM)|5mg发货周期:1～3天产品价格:询价本产品仅可用于科研实验,严禁用于其他非科研用途!本产品为酪氨酸激酶抑制剂。注:本品仅可用于科研实验,严禁用于临床医疗及其他用途!CAS号:1021950-26-4纯度:99.78%分子式:C31H31FN6O5分子量:586.61结构式:储存条件:-20℃,有效期2...
Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? Tyrosine kinases are important cellular signaling proteins that have a variety of biological activities including cell proliferation and migration. Multipl... Kristy,J.,GotinkHenk,... - 《Angiogenesis》 被引量: 385发表: ...
Mechanisms of action in NIH3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity[J]. Biochem Pharmacol,1990,39:18Linassier;C;Pierre;M;Le;Pecq;J;B;Pierre;J.Mechanism of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity....
英文名称:VEGFRTyrosineKinaseInhibitorII 品牌:MedBio 分子式:C19H16ClN3O 货号:MED19478 产地:上海 纯度:98% 是否进口:否 产品用途:VEGFR抑制剂 更多产品规格请登录MedBio官网或者联系我们。MedBio为生命科学和医药研发人员提供3W+抑制剂、激动剂、荧光探针、mRNA转录、生物化工、无毒染料、医药中间体、植物提取物、IV...
Chan F, Sun C, Perumal M, Nguyen QD, Bavetsias V, McDonald E, Martins V, Wilsher NE, Raynaud FI, Valenti M, Eccles S, Te Poele R, Workman P, Aboagye EO, Linardopoulos S (2007) Mechanism of action of the Aurora kinase inhibitor CCT129202 and in vivo quantification of biological act...
369种酪氨酸激酶抑制剂化合物分子库的集合,可用于高通量筛选(HTS)和高内涵筛选(HCS)。 酪氨酸激酶是细胞信号通路中的关键分子,也是很多药物研发的重要靶点,其中受体酪氨酸激酶涵盖胰岛素受体和多种生长因子受体,酪氨酸激酶抑制剂可作用于酪氨酸激酶,如EGFR、VEGFR、FGFR、NGFR、SRC、JAK和c-Met等,在调控细胞生长、分...
Kinase inhibitors, including TKIs, are often classified into six types based on the mechanism of action, but there is no uniformity.22,23,24Type I kinase inhibitors, including cabozantinib, crizotinib, and gefitinib, compete with substrates and bind to the ATP-binding pocket of the active ...
Gifitinib is a kind of new molecular targeted cancer drugs which is a kind of tyrosine kinase inhibitor of epidermal growth factor receptor. 吉非替尼是一种新型的分子靶向抗癌药物。它是一种表皮生长因子受体酪氨酸激酶抑制剂,通过阻断酪氨酸激酶信号传导通路抑制肿瘤的生长。 www.fabiao.net 5. Investiga...